Company Research Report: BariaTek Medical

Company Overview

• Name: BariaTek Medical

• Mission: BariaTek is focused on tackling the obesity pandemic by developing minimally invasive solutions for bariatric surgeons and endoscopists. Their solutions aim to match the efficacy of traditional bypass surgeries while surpassing them in safety, ease of use, reversibility, and cost-effectiveness.

• Founded By: No information is available.

• Key People: Youssef Biadillah (CEO at BariaTek), Simon Menand (Head of Manufacturing), Claudia Grajeda-Iglesias (R&D Project Manager), Antoine Pau (Senior Partner, Life Sciences).

• Headquartered: Paris, Île-de-France, France

• Number of Employees: 11-50

• Revenue: No information is available.

• Known For: BariaTek is known for its innovative approach in treating obesity through non-invasive endoscopic devices, specifically the BariTon™, which mimics the efficacy of sleeve gastrectomy and bypass surgery without the associated invasiveness.

Products

• Product Offered: BariTon™

• High-Level Description: The BariTon™ is a soft, atraumatic, and reversible implant delivered via endoscopy through the mouth in an outpatient setting. It features both gastric and intestinal components designed to reduce food intake and calorie absorption.

• Key Features:

• Non-surgical, involves no sutures, staples, or metal parts.

• Minimally invasive, reversible implant.

• Designed to offer efficacy similar to sleeve gastrectomy and bypass surgery.

• Promotes superior safety, ease of use, and cost efficiency.

Recent Developments

• Human Feasibility Study: BariaTek Medical is conducting a human feasibility study to assess the BariTon™'s safety and efficacy at two locations: The BMI Clinic in Sydney, Australia, and The Republic Center of Surgery in Tashkent, Uzbekistan.

• New Product Launch: BariTon™ device has been introduced and implanted for the first time as a potential game-changer in weight management.

• Recent Financing: Received €1.5M DeepTech non-dilutive financing from Bpifrance to advance the clinical trials for their BariTon™ device aimed at treating obesity and diabetes.

• In Media:

• Featured on France's BFMTV highlighting the launch of their first-in-human clinical study.

• Appeared in Bariatric News discussing the sustainable advantages of their BariTon™ device compared to existing surgical options.

• New Partnerships: No specific partnerships detailed, but collaborations inferred with healthcare facilities conducting the human feasibility studies.

Overall, BariaTek Medical is actively progressing in providing innovative, minimally invasive solutions to manage obesity, with their BariTon™ device currently undergoing critical feasibility assessments to ensure its effectiveness and safety.